Virginia Retirement Systems’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$331K Sell
12,362
-1,200
-9% -$30.9K ﹤0.01% 831
2025
Q3
$361K Buy
13,562
+4,800
+55% +$124K ﹤0.01% 814
2025
Q2
$201K Sell
8,762
-800
-8% -$19.9K ﹤0.01% 902
2025
Q1
$277K Buy
+9,562
New +$305K ﹤0.01% 899
2023
Q3
$1.05M Sell
22,800
-6,500
-22% -$355K 0.01% 502
2023
Q2
$1.68M Buy
29,300
+2,400
+9% +$106K 0.02% 397
2023
Q1
$1.01M Buy
26,900
+1,300
+5% +$42.6K 0.01% 546
2022
Q4
$717K Buy
25,600
+8,900
+53% +$258K 0.01% 717
2022
Q3
$469K Buy
+16,700
New +$545K 0.01% 818

Other funds holding AMPH

Virginia Retirement Systems's AMPH Position: Q4 2025 in Review

Virginia Retirement Systems reduced its Amphastar Pharmaceuticals (AMPH) stake by 8.8% in Q4 2025, selling an estimated $30.9K and leaving 12,362 shares worth $331K. The position accounts for ﹤0.01% of the portfolio, ranked #831.

Virginia Retirement Systems first reported a position in AMPH in Q3 2022 and has held it in 9 quarters since. The position peaked at $1.68M in Q2 2023. 235 funds tracked by Wall St. Rank hold AMPH as of Q4 2025.

  • Virginia Retirement Systems held 12,362 shares of Amphastar Pharmaceuticals worth $331K as of Q4 2025.
  • Virginia Retirement Systems sold 1,200 Amphastar Pharmaceuticals shares in Q4 2025, an estimated $30.9K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q4 2025, its #831 holding.
  • Virginia Retirement Systems first reported a position in Amphastar Pharmaceuticals in Q3 2022 and has held it in 9 quarters since.
  • Virginia Retirement Systems's Amphastar Pharmaceuticals position peaked at $1.68M in Q2 2023.
  • 235 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.